Abstract:Since the ataxia telangiectasia mutated (ATM) protein plays crucial roles in repair of double-stranded DNA breaks, control of cell cycle checkpoints, and radiosensitivity, we hypothesized that variations in this gene might be associated with esophageal squamous cell carcinoma(ESCC)radiation response. A total of 243 ESCC patients receiving preoperative radiation therapy (RT) between 1980 and 2007 were included in this study. RT was administered as conventional simulation to the anterior and posterior fields for about DT 40 Gy/20F/4 wks. Patients underwent esophagectomy approximately 4-8 weeks after RT. Tumor regression grade(TRG) was used to grade radiation response. Grade 1, complete (0% residual tumor; Grade 1a) or subtotal tumor regression (<10% residual tumor per tumor bed; Grade 1b); Grade 2, partial tumor regression (10-50% residual tumor per tumor bed), and Grade 3, minimal or no tumor regression (>50% residual tumor per tumor bed). Four haplotype-tagging single nucleotide polymorphisms (SNPs) in the ATM gene were genotyped by the Sequenom MassARRAY system. For pathologic response to radiation, multivariate logistic regression analysis was done to estimate adjusted odds ratios (ORs) along with the corresponding 95% confidence intervals (CIs) for each polymorphism. The median follow-up time was 28.4 month. After radiation therapy,TRG1-3 rate were 38.7% (n = 94), 35.8% (n = 87), 25.5% (n = 62). In multivariate Cox regression models adjusted for other clinical predictors, ATM-111G>A and 49238 T>C variants were independently associated with radiosensitivity. Comparing TRG2-3, ATM-111AA genotype was associated significantly with TRG1 than AG genotype (adjusted OR = 0.53; 95% CI = 0.29-0.97; p = 0.039) or AG + GG genotype (adjusted OR = 0.52; 95% CI = 1.16-5.28; p = 0.018). Comparing TRG1, ATM 49238CC genotype was associated significantly with TRG3 than CC + TT genotype (adjusted OR = 2.00; 95% CI = 0.92-4.34; p = 0.079). All ATM SNPs were not significantly associated with improved survival and recurrence risk. This study strongly suggest the polymorphisms of ATM-111 G>A and ATM 49238 T>C should be useful as two potential predictive biomarkers of radiation therapy response in esophageal cancer patients treated with preoperative radiation therapy.

A Novel ATM Antisense Transcript ATM-AS Positively Regulates ATM Expression in Normal and Breast Cancer Cells

Discovery of a Pathogenic Variant Rs139379666 (p. P2974L) in ATM for Breast Cancer Risk in Chinese Populations

Expression patterns of theATM gene in mammary tissues and their associations with breast cancer survival

Estrogen Receptor Α Regulates ATM Expression Through Mirnas in Breast Cancer

Mir-18A Impairs DNA Damage Response Through Downregulation of Ataxia Telangiectasia Mutated (ATM) Kinase.

ATM Polymorphisms Are Associated with Radiosensitivity for Patients with Esophageal Squamous Cell Carcinoma Underwent Preoperative Radiation Therapy

Possession of ATM sequence variants as predictor for late normal tissue responses in breast cancer patients treated with radiotherapy

Inhibition of ATM promotes PD-L1 expression by activating JNK/c-Jun/TNF-α signaling axis in triple-negative breast cancer

Antisense Inhibition of ATM Gene Enhances the Radiosensitivity of Head and Neck Squamous Cell Carcinoma in Mice

Identification of an Ataxia Telangiectasia-Mutated Protein Mediated Surveillance System to Regulate Bcl-2 Overexpression

STAT3 And PD-L1 Are Negatively Regulated By ATM And Impact On The Prognosis Of Triple Negative Breast Cancer Patients With Low ATM Expression

The DNA repair kinase ATM regulates CD13 expression and cell migration

Discovery of novel ataxia telangiectasia mutated (ATM) kinase modulators: Computational simulation, biological evaluation and cancer combinational chemotherapy study

P1.03-25 the Frequency and Prognosis of ATM Mutations in Chinese Non-Small-Cell Lung Cancer Patients

The association between ATM D1853N polymorphism and breast cancer susceptibility: a meta-analysis

Two-stage case-control study of common ATM gene variants in relation to breast cancer risk

ATM is a Prognostic Biomarker of Survival in Head and Neck Squamous Cell Carcinoma Patients

Effect of down-regulating expression of ataxia telangiectasia mutated on radiosensitivity to laryngeal squamous cell carcinoma in vivo

ATM modulates nuclear mechanics by regulating lamin A levels

Expression status of ataxia-telangiectasia-mutated gene correlated with prognosis in advanced gastric cancer.

The landscape of ATM alteration in Chinese solid tumor patients.